跳至主要内容
临床试验/ISRCTN73797340
ISRCTN73797340已完成不适用

A randomised study of oral versus intravenous chemotherapy in poor prognosis small cell lung cancer (SCLC)

K Co-ordinating Committee for Cancer Research (UKCCCR)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Histologically or cytologically proven SCLC
  • 2. Patients with extensive disease and poor prognosis, i.e., Eastern Cooperative Oncology Group (ECOG) performance 2 or 3 or alkaline phosphatase >1.5 upper limit normal range
  • 3. Patients 75 years and over, whatever stage of disease, deemed fit for randomisation
  • 4. No previous malignancy, except non-melanomatous skin cancer in the preceding 3 years
  • 5. No medical contraindications to treatment
  • 6. Adequate renal function

排除标准

  • Not provided at time of registration

研究者

发起方
K Co-ordinating Committee for Cancer Research (UKCCCR)

相似试验